Ledger. Australian venture funding, tracked

Founder, Cytopia

Professor Andrew F Wilks

Coverage

Stories naming Professor Andrew F Wilks. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Funding announcement

Professor got nothing from the $2.8b sale of his molecule, and that's okay

Profile of scientist-entrepreneur Andrew Wilks covering the GSK sale of his cancer molecule, his SYNthesis BioVentures fund's family-office backers, and portfolio plays including Aculeus Therapeutics.

Fund close $30m

Andrew Wilks in Weekend Australian

Profile of scientist-entrepreneur Andrew Wilks tracing his path from cancer research to founding drug developer Cytopia and launching SYNthesis BioVentures, a therapeutics fund that recently secured $30 million from wealthy individuals and family offices.

Something wrong? Tell us